Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer

Fig. 5

Influence of different m6A risk groups on genetic variation of patients with CESC. A Mutation profiles of common tumorigenesis drivers in the high- and low-risk patient groups. In the waterfall diagram, mutation information of each gene in each sample is displayed, and various colors indicate different mutation types. The section above the legend shows the mutation load. B The tumor mutation levels were significantly reduced in high-risk patients compared with those in low-risk patients (P = 0.035). C Tumor neoantigen levels were significantly lower in high-risk patients than in low-risk patients (P = 0.0079). D, E Changes in gene copy number levels in the high- and low-risk groups, where red represents genes with significantly increased copy numbers and blue represents genes with significantly missing copy numbers

Back to article page